Science Daily — McGill University researchers have discovered how the antiviral agent foscarnet inhibits HIV replication, laying the groundwork for the development of similar but less toxic drugs. Their findings have been published in the February issue of the Journal of Biological Chemistry.>>> Discuss This Story
